Prostate kallikrein allergen
AssigneePhadia AB
InventorsLars Mattsson, Jonas Lidholm, Henrik Everberg
Life of this patent
Estimating the term…
Loading patent…
AssigneePhadia AB
InventorsLars Mattsson, Jonas Lidholm, Henrik Everberg
Estimating the term…
Methods for treatment of a Type I allergy in a mammal comprise administering to an individual in need of such treatment a polypeptide of SEQ ID NO: 1 or the mature protein, amino acids 25-260, of the polypeptide of SEQ ID NO: 1, or a fragment of the polypeptide or the mature protein, which fragment shares epitopes for antibodies with the polypeptide or the mature protein, respectively, or a hypoallergenic form thereof that is modified to abrogate or attenuate its IgE binding response. Diagnostic kits comprise the polypeptide of SEQ ID NO: 1 or the mature protein, amino acids 25-260, of the polypeptide of SEQ ID NO: 1, immobilized on a solid support.
A method for treatment of a Type I allergy in a mammal, comprising administering to an individual in need of such treatment a polypeptide of SEQ ID NO:
A diagnostic kit, comprising the polypeptide of SEQ ID NO:
Dependencies are inferred from the claim text.